Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors
Our study showed older age for JAK-i initiation, a lower overall latency period, and lower use of prior biologic disease-modifying antirheumatic drug when compared with existing data in the literature. The main motive for JAK-i withdrawal was nonmedical reasons. Adverse events were nonsevere; interestingly, there was only 1 case of herpes zoster and no reports of malignancy or thrombosis.
Authors
- Beatriz Alcalá‐Carmona (ORCID: https://orcid.org/0000-0002-0985-5609)
- Fedra Irazoque-Palazuelos
- Guillermo Arturo Guaracha-Basáñez (ORCID: https://orcid.org/0000-0001-8060-7301)
- César Pacheco‐Tena (ORCID: https://orcid.org/0000-0002-0793-8988)
- Javier Merayo‐Chalico (ORCID: https://orcid.org/0000-0002-5870-0523)
- I. J. Colunga-Pedraza (ORCID: https://orcid.org/0000-0002-2786-5843)
- David Vega‐Morales (ORCID: https://orcid.org/0000-0003-0651-2202)
- Yatzil Reyna-Juarez
- Sandra Carrillo-Vázquez
- Julio Casasola-Vargas (ORCID: https://orcid.org/0000-0003-2853-1404)
- D. X. Xibille Friedmann (ORCID: https://orcid.org/0000-0002-7892-8269)
- Estefanía Torres-Valdez
- Jiram Torres‐Ruiz (ORCID: https://orcid.org/0000-0002-7882-1488)
- Vijaya Rivera-Terán (ORCID: https://orcid.org/0009-0001-2086-459X)
- Angel Alejandro Castillo-Ortiz
- Luis Francisco Valdés-Corona
Institutions
- Autonomous University of Chihuahua (MX)
- El Colegio de México (MX)
- Mexican Social Security Institute (MX)
- Damascus Hospital (SY)
- Secretaria de Salud (MX)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Sociedad Española de Reumatología (ES)
- Secretaria de Salud (HN)
- Hospital General De Zona (MX)
- Asociación Mexicana de Psicología y Desarrollo Comunitario (MX)
- Centro Médico ABC (MX)
- Institute for Social Security and Services for State Workers (MX)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1097/rhu.0000000000002269
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67